{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T16:01:09Z","timestamp":1782316869395,"version":"3.54.5"},"reference-count":50,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,9,13]],"date-time":"2024-09-13T00:00:00Z","timestamp":1726185600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Psychiatry"],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Insomnia is a prevalent disorder that impacts quality of life and leads to significant economic costs. Treatment includes both non-medication and pharmacological interventions, with international guidelines recommending cognitive behavioral therapy for insomnia (CBT-I) as the first-line treatment.<\/jats:p><\/jats:sec><jats:sec><jats:title>Objective<\/jats:title><jats:p>To describe current insomnia treatment practices in South Korea, focusing on pharmacological and non-medication treatments, and to identify gaps in guideline implementation.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>This cohort study used data from the Korea National Health Insurance Service-National Sample Cohort (NHIS-NSC) from 2002 to 2019 and identified 18,003 patients newly diagnosed with insomnia between 2015 and 2019. This study analyzed treatment patterns and utilization rates.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Of the 18,003 patients, 16,181 (89.9%) received pharmacological treatment, resulting in 35,638 prescriptions. Zolpidem (60%) and benzodiazepines (30-40%) were the most prescribed medications. Most patients were treated in clinics, with consistent dosages and increasing treatment lengths. Psychotherapy claims rose from 3.20% in 2015 to 9.14% in 2019, particularly in general hospitals (22.06% to 48.37%), but remained low in clinics (1.26% to 2.08%).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Pharmacological treatments dominate insomnia management in South Korea, with CBT-I being underutilized. Future efforts should focus on integrating non-pharmacological treatment into routine practice and exploring treatment risks and effectiveness based on patient demographics.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fpsyt.2024.1453550","type":"journal-article","created":{"date-parts":[[2024,9,13]],"date-time":"2024-09-13T04:55:34Z","timestamp":1726203334000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":7,"title":["From guidelines to bedside - insomnia treatment practices in South Korea: a nationwide cohort study"],"prefix":"10.3389","volume":"15","author":[{"given":"Daa Un","family":"Moon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaoyan","family":"Piao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Do Hyun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Euna","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,9,13]]},"reference":[{"key":"B1","volume-title":"DSM-5 Task Force. Diagnostic and statistical manual of mental disorders: DSM-5\u2122","year":"2013"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1378\/chest.14-0970","article-title":"International classification of sleep disorders","volume":"146","author":"Sateia","year":"2014","journal-title":"Chest"},{"key":"B3","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1016\/j.biopsych.2010.10.023","article-title":"Prevalence and perceived health associated with insomnia based on DSM-IV-TR; international statistical classification of diseases and related health problems, tenth revision; and research diagnostic criteria\/international classification of sleep disorders, criteria: results from the America insomnia survey","volume":"69","author":"Roth","year":"2011","journal-title":"Biol Psychiatry"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.sleep.2009.07.008","article-title":"Epidemiological and clinical relevance of insomnia diagnosis algorithms according to the DSM-IV and the International Classification of Sleep Disorders (ICSD)","volume":"10","author":"Ohayon","year":"2009","journal-title":"Sleep Med"},{"key":"B5","doi-asserted-by":"publisher","first-page":"zsab258","DOI":"10.1093\/sleep\/zsab258","article-title":"Prevalent, incident, and persistent insomnia in a population-based cohort tested before (2018) and during the first-wave of COVID-19 pandemic (2020)","volume":"45","author":"Morin","year":"2022","journal-title":"Sleep"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2023-075809","article-title":"Elevated prevalence and treatment of sleep disorders from 2011 to 2020: a nationwide population-based retrospective cohort study in Korea","volume":"14","author":"Ahn","year":"2024","journal-title":"BMJ Open"},{"key":"B7","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.sleep.2011.03.020","article-title":"Chronic insomnia, quality-of-life, and utility scores: comparison with good sleepers in a cross-sectional international survey","volume":"13","author":"L\u00e9ger","year":"2012","journal-title":"Sleep Med"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jocn.2021.05.039","article-title":"The association between insomnia and the risk of metabolic syndrome: A systematic review and meta-analysis","volume":"89","author":"Zhang","year":"2021","journal-title":"J Clin Neurosci"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1216951110","article-title":"Impact of insufficient sleep on total daily energy expenditure, food intake, and weight gain","volume":"110","author":"Markwald","year":"2013","journal-title":"Proc Natl Acad Sci"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1186\/2046-4053-3-18","article-title":"The association between sleep disturbances and suicidal behaviors in patients with psychiatric diagnoses: a systematic review and meta-analysis","volume":"3","author":"Malik","year":"2014","journal-title":"Systematic Rev"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2011.01.011","article-title":"Insomnia as a predictor of depression: a meta-analytic evaluation of longitudinal epidemiological studies","volume":"135","author":"Baglioni","year":"2011","journal-title":"J Affect Disord"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.5665\/sleep.3916","article-title":"Stress and sleep reactivity: a prospective investigation of the stress-diathesis model of insomnia","volume":"37","author":"Drake","year":"2014","journal-title":"Sleep"},{"key":"B13","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.amjmed.2014.10.015","article-title":"Persistent insomnia is associated with mortality risk","volume":"128","author":"Parthasarathy","year":"2015","journal-title":"Am J Med"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/0006-3223(95)00188-3","article-title":"Sleep disturbance and psychiatric disorders: a longitudinal epidemiological study of young adults","volume":"39","author":"Breslau","year":"1996","journal-title":"Biol Psychiatry"},{"key":"B15","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.smrv.2015.11.004","article-title":"Health economics of insomnia treatments: the return on investment for a good night\u2019s sleep","volume":"30","author":"Wickwire","year":"2016","journal-title":"Sleep Med Rev"},{"key":"B16","first-page":"55","article-title":"The economic burden of insomnia: direct and indirect costs for individuals with insomnia syndrome, insomnia symptoms, and good sleepers","volume":"32","author":"Daley","year":"2009","journal-title":"Sleep"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1002\/wps.20674","article-title":"The assessment and management of insomnia: an update","volume":"18","author":"Krystal","year":"2019","journal-title":"World Psychiatry"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(22)00878-9","article-title":"Comparative effects of pharmacological interventions for the acute and long-term management of insomnia disorder in adults: a systematic review and network meta-analysis","volume":"400","author":"De Crescenzo","year":"2022","journal-title":"Lancet"},{"key":"B19","article-title":"Korean clinical practice guideline for management of insomnia in adults","volume":"10","author":"Chung","year":"2019","journal-title":"Korean Neuropsychiatr Assoc"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.5664\/jcsm.6470","article-title":"Clinical practice guideline for the pharmacologic treatment of chronic insomnia in adults: an American Academy of Sleep Medicine clinical practice guideline","volume":"13","author":"Sateia","year":"2017","journal-title":"J Clin Sleep Med"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1111\/jsr.14035","article-title":"The European Insomnia Guideline: An update on the diagnosis and treatment of insomnia 2023","volume":"32","author":"Riemann","year":"2023","journal-title":"J Sleep Res"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.30773\/pi.2020.0146","article-title":"Korean clinical practice guideline for the diagnosis and treatment of insomnia in adults","volume":"17","author":"Choi","year":"2020","journal-title":"Psychiatry Invest"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.7326\/M15-2175","article-title":"Management of chronic insomnia disorder in adults: a clinical practice guideline from the American College of Physicians","volume":"165","author":"Qaseem","year":"2016","journal-title":"Ann Internal Med"},{"key":"B24","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.smrv.2017.02.001","article-title":"Cognitive and behavioral therapies in the treatment of insomnia: a meta-analysis","volume":"38","author":"Van Straten","year":"2018","journal-title":"Sleep Med Rev"},{"key":"B25","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.smrv.2014.05.001","article-title":"A meta-analysis of group cognitive behavioral therapy for insomnia","volume":"19","author":"Koffel","year":"2015","journal-title":"Sleep Med Rev"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2015.3006","article-title":"Cognitive behavioral therapy for insomnia comorbid with psychiatric and medical conditions: a meta-analysis","volume":"175","author":"Wu","year":"2015","journal-title":"JAMA Internal Med"},{"key":"B27","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1176\/appi.ajp.159.1.5","article-title":"Comparative meta-analysis of pharmacotherapy and behavior therapy for persistent insomnia","volume":"159","author":"Smith","year":"2002","journal-title":"Am J Psychiatry"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1001\/jama.285.14.1856","article-title":"Cognitive behavioral therapy for treatment of chronic primary insomnia: a randomized controlled trial","volume":"285","author":"Edinger","year":"2001","journal-title":"JAMA"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0142258","article-title":"Internet-based cognitive behavioral therapy for insomnia (ICBT-i) improves comorbid anxiety and depression\u2014a meta-analysis of randomized controlled trials","volume":"10","author":"Ye","year":"2015","journal-title":"PloS One"},{"key":"B30","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1001\/jamapsychiatry.2018.2745","article-title":"Effect of digital cognitive behavioral therapy for insomnia on health, psychological well-being, and sleep-related quality of life: a randomized clinical trial","volume":"76","author":"Espie","year":"2019","journal-title":"JAMA Psychiatry"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1001\/jamapsychiatry.2016.3431","article-title":"Should internet cognitive behavioral therapy for insomnia be the primary treatment option for insomnia?: Toward getting more SHUTi","volume":"74","author":"Krystal","year":"2017","journal-title":"JAMA Psychiatry"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1177\/1559827619867677","article-title":"Cognitive-behavioral therapy for insomnia: an effective and underutilized treatment for insomnia","volume":"13","author":"Rossman","year":"2019","journal-title":"Am J Lifestyle Med"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.7599\/hmr.2013.33.4.210","article-title":"Cognitive behavioral therapy of insomnia","volume":"33","author":"Jang","year":"2013","journal-title":"Hanyang Med Rev"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.5664\/jcsm.3096","article-title":"Master\u2019s-level practitioners as cognitive behavioral therapy for insomnia providers: an underutilized resource","volume":"9","author":"Fields","year":"2013","journal-title":"J Clin Sleep Med"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1111\/jsr.12503","article-title":"Insomnia management in prisons in england and wales: A mixed-methods study","volume":"26","author":"Dewa","year":"2017","journal-title":"J Sleep Res"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1016\/j.smrv.2008.06.001","article-title":"The treatments of chronic insomnia: A review of benzodiazepine receptor agonists and psychological and behavioral therapies","volume":"13","author":"Riemann","year":"2009","journal-title":"Sleep Med Rev"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.18f12340","article-title":"Sedative hypnotics and the risk of falls and fractures in the elderly","volume":"79","author":"Andrade","year":"2018","journal-title":"J Clin Psychiatry"},{"key":"B38","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/S0140-6736(11)60750-2","article-title":"Chronic insomnia","volume":"2012","author":"Morin","year":"9821","journal-title":"Lancet"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1080\/17425255.2020.1817380","article-title":"Clinical pharmacology, efficacy, and safety of orexin receptor antagonists for the treatment of insomnia disorders","volume":"16","author":"Muehlan","year":"2020","journal-title":"Expert Opin Drug Metab Toxicology"},{"key":"B40","doi-asserted-by":"publisher","first-page":"zsz286","DOI":"10.1093\/sleep\/zsz286","article-title":"Quantitative analysis of the placebo response in pharmacotherapy of insomnia and its application in clinical trials","volume":"43","author":"Zheng","year":"2020","journal-title":"Sleep"},{"key":"B41","volume-title":"The ICD-10 classification of mental and behavioural disorders: clinical descriptions and diagnostic guidelines","year":"1992"},{"key":"B42","volume-title":"Korea legislation research institute","year":"2024"},{"key":"B43","unstructured":"Anatomic therapeutic chemical (ATC) and defined daily dose (DDD) toolkit2024"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2024.102507","article-title":"Prescribing and deprescribing guidance for benzodiazepine and benzodiazepine receptor agonist use in adults with depression, anxiety, and insomnia: an international scoping review","volume":"70","author":"Brandt","year":"2024","journal-title":"eClinicalMedicine"},{"key":"B45","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1001\/jama.2016.19004","article-title":"Management of chronic insomnia disorder in adults","volume":"317","author":"Medalie","year":"2017","journal-title":"JAMA"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.22106","article-title":"Balancing the risks and benefits of benzodiazepines","volume":"325","author":"Hirschtritt","year":"2021","journal-title":"JAMA"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1177\/0269881119855343","article-title":"British Association for Psychopharmacology consensus statement on evidence-based treatment of insomnia, parasomnias and circadian rhythm disorders: an update","volume":"33","author":"Wilson","year":"2019","journal-title":"J Psychopharmacology"},{"key":"B48","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1177\/15346501221145944","article-title":"Therapist-assisted internet-delivered cognitive behavioral therapy for insomnia: A case report","volume":"22","author":"Landy","year":"2023","journal-title":"Clin Case Stud"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.3390\/brainsci9120371","article-title":"Co-morbid insomnia and sleep apnea (COMISA): prevalence, consequences, methodological considerations, and recent randomized controlled trials","volume":"9","author":"Sweetman","year":"2019","journal-title":"Brain Sci"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.5664\/jcsm.6988","article-title":"Comorbid insomnia with obstructive sleep apnea: clinical characteristics and risk factors","volume":"14","author":"Cho","year":"2018","journal-title":"J Clin Sleep Med"}],"container-title":["Frontiers in Psychiatry"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyt.2024.1453550\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,13]],"date-time":"2024-09-13T04:55:39Z","timestamp":1726203339000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyt.2024.1453550\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,13]]},"references-count":50,"alternative-id":["10.3389\/fpsyt.2024.1453550"],"URL":"https:\/\/doi.org\/10.3389\/fpsyt.2024.1453550","relation":{},"ISSN":["1664-0640"],"issn-type":[{"value":"1664-0640","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,13]]},"article-number":"1453550"}}